Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Jecure Therapeutics
Biotech
Oncology, RNA biotech 858 Therapeutics inks $60M series A
The team behind Quanticel and Jecure is ready for its next venture: launching RNA biotech 858 Therapeutics with a $60 million series A fundraising.
Emmy Lucas
Sep 21, 2021 8:00am
Genentech snaps up NASH-focused Jecure Therapeutics
Nov 28, 2018 9:49am
Versant’s Jecure Therapeutics debuts with a focus on NASH, fibrosis
Feb 15, 2017 8:36am
